Purchase of own shares – final notice – Biotech Investments

Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice

The share buyback of Drägerwerk AG & Co. KGaA (“Dräger”), which had begun on October 7, 2024, was completed on January 20, 2025. A total of 77,316 preferred shares were bought back during this period. The start of the buyback was announced on October 1, 2024. On November 22, 2024, Dräger announced the extension of the buyback.

The acquisition of the preferred shares served the purpose of fulfilling obligations relating to an employee stock program within the meaning of article 5, paragraph 2 (c) of the Regulation (EU) No 596/2014. The Executive Board did not participate in the program due to the new regulations on share-based remuneration.

A bank mandated by Dräger conducted the buyback of the Dräger preference shares exclusively on a stock exchange.

In accordance with Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052, information about the transactions is available on the Company’s website (www.draeger.com) in the Investor Relations section (www.draeger.com/en_corp/Investor-Relations/Share).

Lübeck, Germany, January 22, 2025

Executive Board
Drägerwerk Verwaltungs AG, acting as the general partner of
Drägerwerk AG & Co. KGaA

Moislinger Allee 53–55
23558 Lübeck, Germany
www.draeger.com